Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.

[1]  F. Collins,et al.  Precision medicine in 2030—seven ways to transform healthcare , 2021, Cell.

[2]  N. Linder,et al.  Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting , 2021, JAMA network open.

[3]  M. Procter,et al.  Abstract PS7-21: Timelines to initiate an adjuvant phase III trial across the globe: A sub-analysis of the APHINITY trial , 2021 .

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  G. Werutsky,et al.  Comprehensive genomic profiling of Brazilian non‐small cell lung cancer patients (GBOT 0118/LACOG0418) , 2020, Thoracic cancer.

[6]  J. Unger,et al.  Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials , 2020, JAMA network open.

[7]  C. Barrios,et al.  Mentoring as an opportunity to improve research and cancer care in Latin America (AAZPIRE project) , 2020, ESMO Open.

[8]  W. Rubinstein,et al.  Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care. , 2020, JCO clinical cancer informatics.

[9]  Robert S. Miller,et al.  Improving Cancer Data Interoperability: The Promise of the Minimal Common Oncology Data Elements (mCODE) Initiative. , 2020, JCO clinical cancer informatics.

[10]  Timóteo Matthies Rico,et al.  Use of Text Messaging (SMS) for the Management of Side Effects in Cancer Patients Undergoing Chemotherapy Treatment: a Randomized Controlled Trial , 2020, Journal of Medical Systems.

[11]  M. Meyerson,et al.  Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations , 2020, medRxiv.

[12]  H. Gómez,et al.  Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience , 2020, PloS one.

[13]  D. Lacombe,et al.  Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer , 2020, Clinical and translational science.

[14]  C. Villarreal-Garza,et al.  Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage , 2020, Women's health.

[15]  Benjamin M Marlin,et al.  Digitizing clinical trials , 2020, npj Digital Medicine.

[16]  C. Barrios,et al.  The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115) , 2020, Breast Cancer Research and Treatment.

[17]  H. Gómez,et al.  Scientific publications in cancer: In Latin-America, strong scientific networks increase productivity (The TENJIN study). , 2020, Journal of clinical epidemiology.

[18]  Ulrich Keilholz,et al.  Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'. , 2020, European journal of cancer.

[19]  J. Wyatt,et al.  Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map , 2020, Trials.

[20]  R. Fleet,et al.  Artificial intelligence in health care: laying the Foundation for Responsible, sustainable, and inclusive innovation in low- and middle-income countries , 2020, Globalization and Health.

[21]  Katherine Payne,et al.  Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  Merrick Schaefer,et al.  Safeguards for the use of artificial intelligence and machine learning in global health. , 2020, Bulletin of the World Health Organization.

[23]  D. Treanor,et al.  Digital pathology for primary diagnosis of screen‐detected breast lesions – experimental data, validation and experience from four centres , 2020, Histopathology.

[24]  Ronnachai Jaroensri,et al.  Artificial intelligence in digital breast pathology: Techniques and applications , 2019, Breast.

[25]  R. Atun,et al.  Artificial Intelligence and its role in surgical care in low-income and middle-income countries. , 2019, The Lancet. Digital health.

[26]  Ahmed Hosny,et al.  Artificial intelligence for global health , 2019, Science.

[27]  A. Seyhan.  Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles , 2019, Translational Medicine Communications.

[28]  Suchi Saria,et al.  Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical Research. , 2019, Digital biomarkers.

[29]  W. Curioso,et al.  Building Capacity and Training for Digital Health: Challenges and Opportunities in Latin America , 2019, Journal of medical Internet research.

[30]  M. Leblanc,et al.  Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications , 2019, JAMA network open.

[31]  Mabel Crescioni,et al.  Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium , 2019, Therapeutic innovation & regulatory science.

[32]  S. Ramsey,et al.  Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer. , 2019, JCO clinical cancer informatics.

[33]  O. Arrieta,et al.  Access to lung cancer therapy in the Mexican population: opportunities for reducing inequity within the health system. , 2019, Salud publica de Mexico.

[34]  M. Drummond,et al.  Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[35]  J. Tabernero,et al.  New clinical trial designs in the era of precision medicine , 2019, Molecular oncology.

[36]  W. Mackillop,et al.  Real-world data: towards achieving the achievable in cancer care , 2019, Nature Reviews Clinical Oncology.

[37]  PR Advisors.  Global overview , 2018, Global Report on Trafficking in Persons.

[38]  Andrew B. Conley,et al.  Genetic ancestry, admixture and health determinants in Latin America , 2018, BMC Genomics.

[39]  J. Kvedar,et al.  A randomized controlled trial of a novel artificial intelligence-based smartphone application to optimize the management of cancer-related pain. , 2018, Journal of Clinical Oncology.

[40]  S. Khozin,et al.  Assessing function of electronic health records for real-world data generation , 2018, BMJ Evidence-Based Medicine.

[41]  M. Thompson,et al.  Social media and clinical trials: The pros and cons gain context when the patient is at the center , 2018, Cancer.

[42]  K. Getz,et al.  Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials , 2018, JAMA network open.

[43]  Jonathan Guo,et al.  The Application of Medical Artificial Intelligence Technology in Rural Areas of Developing Countries , 2018, Health equity.

[44]  Yanik J. Bababekov,et al.  Training for our digital future: a human-centered design approach to graduate medical education for aspiring clinician-innovators , 2018, npj Digital Medicine.

[45]  J. Miranda,et al.  Advancing health through research partnerships in Latin America , 2018, British Medical Journal.

[46]  Samuel L Volchenboum,et al.  Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials. , 2018, JCO clinical cancer informatics.

[47]  Ana Maria Lopez,et al.  Telemedicine in Cancer Care. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[48]  E. Martínez-Herrera,et al.  Effectiveness of text messages, calls and e-mail on adherence to medical appointments. Review of systematic reviews and meta-analysis , 2018 .

[49]  K. Holmes,et al.  Global migration of clinical research during the era of trial registration , 2018, PloS one.

[50]  A. Amato,et al.  International Clinical Trials in Latin American and Caribbean Countries: Research and Development to Meet Local Health Needs , 2018, Front. Pharmacol..

[51]  Karina dos Santos Machado,et al.  Text Messaging (SMS) Helping Cancer Care in Patients Undergoing Chemotherapy Treatment: a Pilot Study , 2017, Journal of Medical Systems.

[52]  F. Vaca-Paniagua,et al.  Cancer Genomic Resources and Present Needs in the Latin American Region , 2017, Public Health Genomics.

[53]  S. Thomsen,et al.  Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities , 2017, BMJ Open.

[54]  A. Evans,et al.  Implementation of Whole Slide Imaging for Clinical Purposes: Issues to Consider From the Perspective of Early Adopters. , 2017, Archives of pathology & laboratory medicine.

[55]  C. Angelo.  Brazilian scientists reeling as federal funds slashed by nearly half , 2017, Nature.

[56]  Daniel Hind,et al.  Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme , 2017, BMJ Open.

[57]  M. Marschollek,et al.  mHealth Application Areas and Technology Combinations , 2017, Methods of information in medicine.

[58]  C. Bandala,et al.  Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents. , 2016, Recent patents on anti-cancer drug discovery.

[59]  O. Podhajcer,et al.  Translational cancer research comes of age in Latin America , 2015, Science Translational Medicine.

[60]  K. Strasser-Weippl,et al.  Progress and remaining challenges for cancer control in Latin America and the Caribbean. , 2015, The Lancet. Oncology.

[61]  Matthew Meyerson,et al.  Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[62]  Wilson Shcolnik,et al.  Clinical Laboratories Accreditation Program of the Brazilian Society of Clinical Pathology/Laboratory Medicine (PALC/SBPC-ML) , 2015, American journal of medical quality : the official journal of the American College of Medical Quality.